Termination of the KIRIN-AMGEN Joint Venture Agreement and Transfer of Interest

A discrete transaction involving the termination of the pharmaceutical R&D joint venture with Amgen, which had continued since 1984, based on the determination that it had fulfilled its original role, and the transfer of the entire 50% interest held.